Myasthenia Gravis (MG)

What is Myasthenia Gravis (MG)?

Myasthenia Gravis is a chronic autoimmune condition that affects how nerves and muscles communicate. Your immune system mistakenly creates antibodies that block or damage the receptors where nerves connect to muscles. This breakdown in communication causes muscle weakness that gets worse with activity and improves with rest.

The condition can affect any voluntary muscles, meaning the muscles you control consciously. Eye muscles are often affected first, causing drooping eyelids or double vision. Muscles that control facial expression, chewing, swallowing, and speaking may also weaken. In more severe cases, breathing muscles can become involved. The weakness typically fluctuates throughout the day and worsens with repeated use of the same muscles.

Myasthenia Gravis affects about 20 out of every 100,000 people in the United States. It can develop at any age but most commonly appears in women under 40 and men over 60. While there is no cure, treatment can control symptoms effectively and allow most people to live full, active lives.

MuSK and LRP4 Antibodies Panel

Pinpoint muscle weakness causes accurately
Reveal autoimmune issues affecting your health
Clarify unexplained fatigue and muscle pain

^$7,400

Symptoms

Drooping of one or both eyelids
Double vision or blurred vision
Weakness in arms, hands, fingers, legs, or neck
Difficulty swallowing or frequent choking
Slurred or nasal speech that worsens with talking
Difficulty chewing, especially with hard foods
Changes in facial expressions or inability to smile
Shortness of breath or difficulty breathing
Muscle weakness that improves with rest
Fatigue that worsens as the day progresses

Symptoms often start mildly and may come and go at first. Many people notice their symptoms worsen with activity, stress, illness, or heat exposure. Some people experience only eye-related symptoms while others develop more widespread muscle weakness.

Causes and risk factors

Myasthenia Gravis occurs when your immune system produces antibodies that attack proteins at the neuromuscular junction, the spot where nerves connect to muscles. In most cases, these antibodies target acetylcholine receptors, which are responsible for receiving chemical signals from nerves. Some people develop antibodies against other proteins like MuSK or LRP4, which also play important roles in nerve-muscle communication. When these proteins are damaged or blocked, muscles cannot receive proper signals from nerves, leading to weakness.

The thymus gland, located in your chest, appears to play a role in triggering this autoimmune response. About 75% of people with Myasthenia Gravis have an abnormal thymus gland, either enlarged or containing a tumor called a thymoma. Risk factors include being female under age 40, being male over age 60, having other autoimmune diseases like thyroid disorders or lupus, and certain genetic factors. Infections, surgery, stress, and some medications can trigger symptom flares in people who already have the condition.

How it's diagnosed

Doctors diagnose Myasthenia Gravis through a combination of physical examination, medical history, and specialized tests. Your doctor will look for muscle weakness that worsens with activity and improves with rest. Blood tests that detect specific antibodies are key to confirming the diagnosis. These tests look for antibodies against acetylcholine receptors, MuSK antibodies, and LRP4 antibodies. About 85% of people with generalized Myasthenia Gravis have detectable antibodies.

Additional testing may include electromyography, which measures electrical activity in muscles, and a test called repetitive nerve stimulation that checks how muscles respond to repeated signals. An ice pack test or edrophonium test may be used to see if muscle weakness temporarily improves. Imaging of the chest with CT or MRI can check for thymus gland abnormalities. Specialized antibody testing for Myasthenia Gravis requires specific lab work that goes beyond standard blood panels. Talk to your doctor about which tests are right for your symptoms.

Treatment options

Medications that improve nerve-muscle communication, such as pyridostigmine
Immunosuppressive drugs like prednisone or azathioprine to reduce antibody production
Thymectomy, surgical removal of the thymus gland, especially if a thymoma is present
Intravenous immunoglobulin therapy for rapid symptom relief during flares
Plasma exchange to temporarily remove harmful antibodies from the blood
Newer biologic medications that target specific immune system pathways
Adequate rest and avoiding overexertion of muscles
Stress management techniques to prevent symptom flares
Avoiding extreme heat and infections that can worsen symptoms
Working with physical and occupational therapists to maintain muscle function

Frequently asked questions

Most people with Myasthenia Gravis experience muscle weakness that changes throughout the day. You might feel relatively strong in the morning but notice your eyelids drooping or speech slurring by afternoon. Activities like chewing, climbing stairs, or holding your arms up become progressively harder with repetition. Rest periods help muscles recover temporarily.

Yes, blood tests can detect antibodies associated with Myasthenia Gravis in about 85% of cases. Tests look for antibodies against acetylcholine receptors, MuSK antibodies, and LRP4 antibodies. These specialized tests require specific lab orders and are typically done when a doctor suspects Myasthenia Gravis based on symptoms. Some people with the condition test negative for all known antibodies.

Myasthenia Gravis does not follow a predictable pattern for everyone. Some people experience symptoms that remain mild and limited to eye muscles. Others develop more widespread weakness that can fluctuate in severity. With proper treatment, many people see significant improvement and can maintain good quality of life. The first few years after diagnosis are often when symptoms are most active.

Common triggers include infections like respiratory illnesses, emotional or physical stress, surgery, extreme temperatures, and certain medications. Some antibiotics, heart medications, and muscle relaxants can worsen symptoms. Menstrual cycles and pregnancy may also affect symptom severity. Identifying and avoiding your personal triggers helps prevent flares and maintain stable muscle function.

While diet alone cannot treat Myasthenia Gravis, certain strategies can help. Eating smaller, more frequent meals reduces chewing fatigue. Choosing soft foods when swallowing is difficult prevents choking. Adequate rest and pacing activities throughout the day helps conserve energy. Stress reduction through meditation or gentle exercise may help prevent flares when combined with medical treatment.

Diagnosis time varies widely depending on symptom severity and which muscles are affected. Some people receive a diagnosis within weeks if eye symptoms are obvious and antibody tests are positive. Others may wait months or longer if symptoms are mild or intermittent. About 15% of people test negative for all known antibodies, making diagnosis more challenging and requiring additional specialized testing.

Treatment duration varies by individual. Some people achieve remission, especially after thymectomy, and can reduce or stop medications over time. Others require long-term medication to control symptoms effectively. Your treatment plan may change as your condition evolves. Regular follow-up with your neurologist helps determine the right balance of medications and monitors for side effects.

Many people with well-controlled Myasthenia Gravis continue working and staying active. The key is finding the right treatment plan and pacing yourself appropriately. Some people need workplace accommodations like flexible schedules or frequent breaks. Light to moderate exercise is often beneficial but should be done under medical guidance. Avoid pushing muscles to exhaustion, which can trigger worsening weakness.

Myasthenia Gravis is neither contagious nor directly inherited in most cases. However, there is a slightly increased risk in families with autoimmune diseases. The condition results from a combination of genetic susceptibility and environmental triggers. A rare form called congenital myasthenic syndrome is inherited genetically but differs from autoimmune Myasthenia Gravis in its cause and treatment.

A myasthenic crisis occurs when breathing muscles become so weak that you cannot breathe adequately on your own. This is a medical emergency requiring immediate hospitalization and often mechanical ventilation. Crises affect about 15 to 20 percent of people with Myasthenia Gravis at some point. Recognizing warning signs like increasing shortness of breath and seeking immediate medical care can prevent life-threatening complications.